Benchmark Reiterates Buy on Select Medical Hldgs, Maintains $39 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bill Sutherland has reiterated a Buy rating on Select Medical Holdings (SEM) and maintained a $39 price target.
May 03, 2024 | 5:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Bill Sutherland reiterates a Buy rating on Select Medical Holdings with a $39 price target.
The reiteration of a Buy rating and maintenance of a $39 price target by a Benchmark analyst suggests a positive outlook for SEM, likely leading to increased investor confidence and potential upward movement in the stock's price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100